{"disease":{"id":"peanut-allergy","name":"peanut allergy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04887441","title":"Allergology: Information, Data and Knowledge Organization","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT04881773","title":"Oral Low Doses Tolerance INduction Study for Peanuts","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT03546413","title":"Follow up of LEAP Participants and Their Families","phase":"","overall_status":"COMPLETED","enrollment_count":1868,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03292484","title":"Longer-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":911,"lead_sponsor_name":"Aimmune Therapeutics, Inc.","has_results":true},{"nct_id":"NCT02635776","title":"Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":555,"lead_sponsor_name":"Aimmune Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03126227","title":"Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":506,"lead_sponsor_name":"Aimmune Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03881696","title":"Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":471,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT03211247","title":"Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":414,"lead_sponsor_name":"DBV Technologies","has_results":true},{"nct_id":"NCT02993107","title":"PALISADE Follow-on Study (ARC004)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":388,"lead_sponsor_name":"Aimmune Therapeutics, Inc.","has_results":true},{"nct_id":"NCT06256146","title":"Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety","phase":"NA","overall_status":"RECRUITING","enrollment_count":360,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT03859700","title":"Follow-up of the EPITOPE Study to Evaluate Long-term Efficacy and Safety of DBV712 in Young Children","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":304,"lead_sponsor_name":"DBV Technologies","has_results":false},{"nct_id":"NCT03852342","title":"Reactive Doses and Times During Oral Food Challenge to Peanut","phase":"","overall_status":"COMPLETED","enrollment_count":262,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT03337542","title":"AR101 Real-World Open-Label Extension Study","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":243,"lead_sponsor_name":"Aimmune Therapeutics, Inc.","has_results":true},{"nct_id":"NCT05503446","title":"Using Commonly Available Food Products To Treat Food Allergy","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":216,"lead_sponsor_name":"University of Southampton","has_results":false},{"nct_id":"NCT03835767","title":"Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03201003","title":"ARTEMIS Peanut Allergy In Children","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":175,"lead_sponsor_name":"Aimmune Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03682770","title":"Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT05671471","title":"Accidental Reactions in Peanut/Tree Nut Allergic Children","phase":"","overall_status":"COMPLETED","enrollment_count":147,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT03736447","title":"Peanut Oral Immunotherapy Study of Early Intervention for Desensitization","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"Aimmune Therapeutics, Inc.","has_results":true},{"nct_id":"NCT05667610","title":"Immune-supportive Diet and Gut Permeability in Allergic Children","phase":"NA","overall_status":"RECRUITING","enrollment_count":132,"lead_sponsor_name":"Onze Lieve Vrouwe Gasthuis","has_results":false},{"nct_id":"NCT03679676","title":"Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":108,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT05165329","title":"A Randomized, Controlled Trial of Probiotic and Peanut Oral Immunotherapy (PPOIT) in Inducing Tolerance in Hong Kong Children With Peanut Allergy Compared With Oral Immunotherapy (OIT) Alone and With Placebo","phase":"NA","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT03907397","title":"Immune Basis and Clinical Implications of Threshold-based Phenotypes of Peanut Allergy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":73,"lead_sponsor_name":"Scott Sicherer","has_results":true},{"nct_id":"NCT07015996","title":"Efficacy of Tezepelumab in Peanut Oral Immunotherapy","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":62,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT03936998","title":"VE416 for Treatment of Food Allergy","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT07439406","title":"Comparing Standard and Autoclaved Peanut Oral Immunotherapy in People With Peanut Allergy","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":57,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT01987817","title":"Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Aimmune Therapeutics, Inc.","has_results":true},{"nct_id":"NCT03532360","title":"Peanut and Tree Nut Desensitization","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":51,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT03513965","title":"Allergy Experience Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Stanford University","has_results":false},{"nct_id":"NCT02198664","title":"Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"Aimmune Therapeutics, Inc.","has_results":true},{"nct_id":"NCT04415593","title":"High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety","phase":"NA","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT05163574","title":"Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral Immunotherapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT07580898","title":"Safety of MOON101 for the Treatment of Peanut Allergy","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"Moonlight Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07349212","title":"UKK-0018 as an Immunotherapeutic for Treatment of Peanut Allergies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Ukko Inc","has_results":false},{"nct_id":"NCT05695261","title":"Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":37,"lead_sponsor_name":"Rima Rachid","has_results":false},{"nct_id":"NCT03648320","title":"The Grown Up Peanut Immunotherapy Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT04603300","title":"OMEGA Study: A Study of the Safety and Feasibility of Up-titration With INT301 in Adults With Sensitivity to Peanut","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Intrommune Therapeutics","has_results":false},{"nct_id":"NCT06331728","title":"Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IGNX001","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"IgGenix Australia Pty Ltd","has_results":false},{"nct_id":"NCT02851277","title":"A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":false},{"nct_id":"NCT03352726","title":"A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"DBV Technologies","has_results":false},{"nct_id":"NCT03793608","title":"Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT03755713","title":"A Study to Evaluate Safety, Tolerability and Immune Response in Adolescents Allergic to Peanut After Receiving Intradermal Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Astellas Pharma Global Development, Inc.","has_results":false},{"nct_id":"NCT02920021","title":"Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"AnaptysBio, Inc.","has_results":true},{"nct_id":"NCT02698033","title":"High Threshold Peanut Challenge Study","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT05138757","title":"Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"University of Chicago","has_results":true},{"nct_id":"NCT03251508","title":"Salvage Peanut Oral Immunotherapy Study","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"University of North Carolina, Chapel Hill","has_results":true},{"nct_id":"NCT05250856","title":"CNP-201 in Subjects With Peanut Allergy","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"COUR Pharmaceutical Development Company, Inc.","has_results":false},{"nct_id":"NCT02960074","title":"Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic Patients","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Rima Rachid","has_results":false},{"nct_id":"NCT03680066","title":"Study to Assess Tolerance of Traces in Peanut/Tree Nut Allergic Children.","phase":"NA","overall_status":"TERMINATED","enrollment_count":15,"lead_sponsor_name":"University Hospital, Geneva","has_results":false},{"nct_id":"NCT04872218","title":"Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Philippe Bégin","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}